Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona.


Journal

JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500

Informations de publication

Date de publication:
10 2021
Historique:
received: 28 07 2021
accepted: 28 08 2021
entrez: 17 8 2022
pubmed: 18 8 2022
medline: 18 8 2022
Statut: epublish

Résumé

Understanding the relative risk of SARS-CoV-2 infection across occupations can inform guidance to protect workers and communities. Less is known about infection risk for first responders and other essential workers than for health care personnel. To compare the prevaccination incidence of SARS-CoV-2 infection among first responders and other essential workers with incidence among health care personnel. This was a prospective cohort study of health care personnel, first responders, and other essential workers in Arizona from July 20, 2020, to March 14, 2021. Participants were seronegative at enrollment, had frequent direct contact with others at work, worked at least 20 hours per week, and submitted weekly nasal swab specimens for real-time reverse transcriptase polymerase chain reaction analysis. Data analyses were performed from April 19, 2021, to June 4, 2021. Occupation was the primary exposure of interest. Confounders assessed were sociodemographic characteristics, health status, community exposure, and work exposure. Crude incidence of SARS-CoV-2 infection was defined as the sum of first positive SARS-CoV-2 infections in participants divided by person-weeks at risk. Negative binomial regression was used to model SARS-CoV-2 infection by occupation to estimate unadjusted and adjusted incidence rate ratios (IRRs). The least absolute shrinkage and selection operator (LASSO) method was used to generate a parsimonious multivariable model. The study cohort comprised 1766 Arizona workers (mean age [SD], 43.8 [11.1] years; 1093 [61.9%] female; 401 [22.7%] were Hispanic and 1530 [86.6%] were White individuals) of whom 44.2% were health care personnel, 22.4% first responders, and 33.4% other essential workers. The cohort was followed up for 23 393 person-weeks. Crude incidence of SARS-CoV-2 infection was 6.7, 13.2, and 7.4 per 1000 person-weeks at risk for health care personnel, first responders, and other essential workers, respectively. In unadjusted models, first responders had twice the incidence of infection as health care personnel (IRRs, 2.01; 95% CI, 1.44-2.79). While attenuated, this risk remained elevated in adjusted LASSO-optimized models (IRR, 1.60; 95% CI, 1.07-2.38). Risk of infection among other essential workers was no different than for health care personnel in unadjusted or adjusted models. This prospective cohort study found that first responders had a higher incidence of SARS-CoV-2 infection than health care personnel, even after adjusting for potential confounding factors. Given their frequent contact with each other and with the public and their high rates of SARS-CoV-2 infection, the safety challenges for first responders warrant greater public health attention and research.

Identifiants

pubmed: 35977166
doi: 10.1001/jamahealthforum.2021.3318
pii: aoi210052
pmc: PMC8727035
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Pagination

e213318

Informations de copyright

Copyright 2021 Ellingson KD et al. JAMA Health Forum.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosures: None reported.

Références

Ann Intern Med. 2021 May;174(5):649-654
pubmed: 33513035
PLoS One. 2020 Apr 28;15(4):e0232452
pubmed: 32343747
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
JAMA. 2021 Mar 2;325(9):823-824
pubmed: 33497433
JAMA. 2020 Oct 13;324(14):1389-1390
pubmed: 32936212
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
JAMA Netw Open. 2021 Mar 1;4(3):e211283
pubmed: 33688967
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
JMIR Res Protoc. 2021 May 26;:
pubmed: 34057904
Occup Med (Lond). 2020 Mar 12;70(1):3-5
pubmed: 32107548

Auteurs

Katherine D Ellingson (KD)

Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of Arizona, Tucson.

Joe K Gerald (JK)

Department of Community, Environment and Policy, University of Arizona, Tucson.

Xiaoxiao Sun (X)

Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of Arizona, Tucson.

James Hollister (J)

Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of Arizona, Tucson.

Karen Lutrick (K)

Department of Family and Community Medicine, University of Arizona, Tucson.

Joel Parker (J)

Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of Arizona, Tucson.

Patrick Rivers (P)

Department of Health Promotion Sciences, University of Arizona, Tucson.

Shawn C Beitel (SC)

Department of Community, Environment and Policy, University of Arizona, Tucson.

Zoe Baccam (Z)

Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of Arizona, Tucson.

Julie Mayo Lamberte (JM)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Lauren Grant (L)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Elizabeth Kim (E)

Arizona Department of Health Services, Phoenix.

Rachana Bhattarai (R)

Arizona Department of Health Services, Phoenix.

Kenneth Komatsu (K)

Arizona Department of Health Services, Phoenix.

Jennifer Meece (J)

Marshfield Laboratories, Marshfield, Wisconsin.

Preeta K Kutty (PK)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Mark G Thompson (MG)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Jefferey L Burgess (JL)

Department of Community, Environment and Policy, University of Arizona, Tucson.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH